Results 101 to 110 of about 57,707 (307)

Protection by Preconditioning and Cardiac Pacing against Ventricular Arrhythmias Resulting from Ischemia and Reperfusiona [PDF]

, 1996
James R. Parratt, Ágnes Végh, Kaszala Karoly, Julius Gy. Papp   +3 more
openalex   +1 more source

Semaglutide normalizes increased cardiomyocyte calcium transients in a rat model of high fat diet‐induced obesity

ESC Heart Failure, Volume 12, Issue 2, Page 1386-1397, April 2025.
Sequeira et al. reveal how the glucagon‐like peptide‐1 receptor agonist (GLP‐1‐RA) semaglutide restores cardiomyocyte function in rats subjected to a high‐fat/high‐fructose diet (HFD). Employing fluorescence‐ and patch‐clamp technology in isolated cardiac myocytes, they demonstrate that semaglutide reverses HFD‐induced activation of L‐type calcium ...
Vasco Sequeira, Julia Theisen, Katharina J. Ermer, Marie Oertel, Anton Xu, David Weissman, Katharina Ecker, Jan Dudek, Martin Fassnacht, Alexander Nickel, Michael Kohlhaas, Christoph Maack, Ulrich Dischinger   +12 more
wiley   +1 more source

Open window mapping for redo accessory pathway ablation in Ebstein anomaly

Indian Pacing and Electrophysiology Journal
Accessory pathway ablation in Ebstein anomaly can be significantly more challenging than in structurally normal hearts. An alternative to the conventional approach to mapping APs is to detect points with a high-density mapping catheter based on an ...
Anindya Ghosh, Akram KA. Mohamed, Sabari Saravanan, Ulhas M. Pandurangi   +3 more
doaj   +1 more source

Relationship Between Changes in Pulse Pressure and Frequency Domain Components of Heart Rate Variability During Short-Term Left Ventricular Pacing in Patients with Cardiac Resynchronization Therapy

, 2016
Bożena Urbanek, Jan Ruta, Krzysztof Kudryński, Paweł Ptaszyński, Artur Klimczak, Jerzy Krzysztof Wranicz   +5 more
openalex   +2 more sources

FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1485-1489, April 2025.
Abstract Aims Inflammation has been implicated in the pathogenesis of desmoplakin (DSP) cardiomyopathy, and retrospective studies have described abnormal myocardial fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in symptomatic patients eventually diagnosed with DSP cardiomyopathy.
Sanjay Divakaran, Vinay Randhawa, Usman A. Tahir, Matthew Robertson, Anam A. Waheed, Anna Perillo, Leanne Barrett, Ron Blankstein, Mark W. Feinberg, Marcelo F. Di Carli, Neal K. Lakdawala   +10 more
wiley   +1 more source

Analysis of immunoinfiltration and EndoMT based on TGF-β signaling pathway-related genes in acute myocardial infarction

Scientific Reports
Acute myocardial infarction (AMI), a critical manifestation of coronary heart disease, presents a complex and not entirely understood etiology. This study investigates the potential role of immune infiltration and endothelial-mesenchymal transition ...
Jun Shen, Junqing Liang, Manzeremu Rejiepu, Zhiqin Ma, Jixian Zhao, Jia Li, Ling Zhang, Ping Yuan, Jianing Wang, Baopeng Tang   +9 more
doaj   +1 more source

8Pre-existing right ventricular paced heart failure patients upgraded to cardiac resynchronisation therapy devices: a retrospective assessment of the functional and clinical benefits [PDF]

, 2017
N. A. Estes Mark
openalex   +1 more source

Upgrade of cardiac resynchronization therapy by utilizing additional His-bundle pacing in a patient with lamin A/C cardiomyopathy: an autopsy case report [PDF]

, 2021
Masako Baba, Kentaro Yoshida, Osamu Igawa, Masayoshi Yamamoto, Akihiko Nogami, Noriyuki Takeyasu, Hitoaki Saitoh   +6 more
openalex   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Clinical Updates in Cardiac Pacing-The Future Is Bright. [PDF]

J Clin Med, 2022
Vandenberk B, Ballantyne BA, Chew DS.
europepmc   +1 more source